Shares of GoodRx Holdings, Inc. (GDRX) are rising more than 16 percent Thursday morning after reporting improved revenue for the fourth quarter, that surpassed the estimates. Revenue outlook for the first-quarter, as well as full-year came in better than estimates.
Revenue for the fourth quarter increased 7 percent to $196.6 million from $184.1 million last year, primarily driven by an 8% increase in monthly active consumers. Analysts on average polled by Thomson-Reuters were expecting revenue of $195.83 million.
For the first quarter, GoodRx sees revenue in the range of $195 million-$198 million above the consensus estimate of $192.91 million.
For the full year, revenue is expected nearly $800 million. The Street view was for $790.53 million.
GDRX, currently at $7.58, has traded in the range of $4.14 - $9.37 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.